MedPath
FDA Approval

Oxazepam

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
August 15, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Oxazepam(30 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Aphena Pharma Solutions - Tennessee, Inc.

Aphena Pharma Solutions - Tennessee, Inc.

128385585

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxazepam

Product Details

NDC Product Code
43353-074
Application Number
ANDA072253
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
April 6, 2012
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
METHYLPARABENInactive
Code: A2I8C7HI9TClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
D&C RED NO. 28Inactive
Code: 767IP0Y5NHClass: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBDClass: IACT
OxazepamActive
Code: 6GOW6DWN2AClass: ACTIBQuantity: 30 mg in 1 1
PROPYLPARABENInactive
Code: Z8IX2SC1OHClass: IACT
GELATINInactive
Code: 2G86QN327LClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath